Study at a glance
What question did the studies ask?
Researchers asked whether vitamin D affects how DNA is packaged and regulated. DNA carries genetic information. Chromatin is DNA together with its associated proteins. Studies measured how accessible DNA was, chemical marks on DNA or proteins, and where proteins that regulate genes were attached to DNA. These are different measurements.
What did the researchers find?
Cell experiments found changes that depended on cell type and timing. Many genes could change activity at DNA regions that were already accessible. In one cell-line study, some accessibility changes became smaller later. That does not establish permanence. A selected one-person blood study found responses over one or two days. Repeated samples were not independent participants.
A pregnancy trial found small differences at selected DNA sites in newborn cord tissue. Overall differences did not meet its standard for a clear result after accounting for the number of sites tested. A larger observational newborn study found no clear associations after a similar statistical adjustment. Neither established lasting changes in children’s gene activity or health.
What does this mean?
Other experiments investigated proteins that package DNA and developmental effects in mice. Cell experiments often used calcitriol, the active vitamin D hormone. Some used a laboratory-made substance that activates the vitamin D receptor, a protein that responds to vitamin D. These differ from oral vitamin D3. The studies do not establish lasting changes that improve people’s health.
Read the full article below ↓Vitamin D-related experiments can change how DNA is packaged, marked or reached by regulatory proteins. Those are different findings, and none automatically proves a lasting change that improves health. This summary compares laboratory models, a selected one-person blood study and human pregnancy research. For the detailed evidence, read Vitamin D, Chromatin Accessibility and Epigenetic Marks: Full Evidence Review.
What do the measurements mean?
DNA carries genetic information. Chromatin is DNA together with its associated proteins. Accessibility tests measure which DNA regions are relatively exposed to an experimental probe. Methylation tests measure selected chemical marks on DNA. Histone tests examine chemical modifications of proteins that help package DNA. Other tests measure where regulatory proteins bind. Vitamin D and Epigenetic Regulation explains these processes.
Gene activity is a separate measurement. An accessible region does not necessarily control a particular nearby gene. A mark can change without a clear expression change. Vitamin D and Gene Expression explains gene activity, and Vitamin D and Nuclear Receptors introduces the receptor family involved in vitamin D signalling.
What did the cell and blood studies find?
In a human monocyte model grown from a blood cancer, calcitriol changed accessibility over two to 48 hours. Monocytes are a type of immune cell. Some regions became less accessible again later. This was not a test after treatment withdrawal and did not establish permanence. Calcitriol is the active vitamin D hormone, not the same exposure as oral vitamin D3. [1]
A selected man studied after three separate monthly doses of vitamin D3 showed blood-cell responses over one or two days. Repeated measurements were not independent participants. A small comparison group did not broadly reproduce all his findings. The different types of cells in each blood sample and the absence of an inactive comparison treatment limited interpretation. [2]
A human laboratory model of supporting tissue in the womb found both increases and decreases in accessibility. Many genes associated with expression changes were near DNA regions that were already accessible. The same cell model was measured repeatedly for accessibility; these were not independent human donors. The data did not establish improved fertility or an actual change in specialised cell identity, a distinction related to Vitamin D and Cell Differentiation. [3]
Other experiments investigated histone marks in kidney-cancer cells and changes between protein complexes that remodel chromatin. The latter combined a laboratory-made vitamin D receptor activator with a separate protein inhibitor in some experiments. Blood-sugar and insulin findings in mice given that combination do not establish ordinary vitamin D3 treatment effects in people. [4] [5]
Liver-cell studies measured related DNA-binding patterns of regulatory proteins. A separate kidney-scarring study included binding tests using purified protein parts, separated from whole cells. Those methods provide different evidence and should not be merged into proof of one identical mechanism. [6] [7]
What did the human pregnancy studies show?
MAVIDOS compared daily vitamin D3 with an inactive comparison treatment, called a placebo, during pregnancy. Small differences appeared at selected DNA sites in newborn cord tissue, but overall findings did not meet the standard for a clear result after accounting for the sites tested. The pregnancy trial excluded very low initial vitamin D levels. The sample was measured at birth, not followed to demonstrate lasting gene activity. [8]
A larger observational study of prenatal vitamin D status and newborn blood found no clear DNA-site associations after accounting for many tests. That limits broad claims about a newborn methylation signature. It does not exclude every possible tissue response. [9]
One mouse study found selected DNA-methylation differences and associated gene-regulatory changes after an early developmental exposure. A second mouse study found variable marks across generations. It did not detect a statistically significant overall dietary effect on the activity of the tested genes in newborn mouse liver. A chemical mark and a change in gene activity are not interchangeable. [10] [11]
What can be concluded?
Vitamin D-related signals can affect selected DNA-packaging and regulatory processes. The effects depend on model, timing and measurement. These studies do not establish a universal permanent programme or lasting changes that improve people’s health. Cell hormone treatment, laboratory-made receptor activators and oral vitamin D3 remain different interventions.
Scientific sources
[1] Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF. Seuter S, Neme A, Carlberg C. Nucleic acids research. 2016;44(9):4090-4104. DOI 10.1093/nar/gkv1519; PMID 26715761.
[2] Chromatin and transcriptional dynamics underlying the immune-modulatory effects of vitamin D3 in vivo. Rybiński M, Ghosh Dastidar R, Zawrotna N, Gospodarska E, Carlberg C. Scientific reports. 2026;16:2997. Published online 18 December 2025. DOI 10.1038/s41598-025-32831-z; PMID 41413700; PMCID PMC12830676.
[3] Increased chromatin accessibility following 1α,25-dihydroxyvitamin D3 treatment in human endometrial stromal cells. Yi M, Bostan H, DeMayo FJ. Toxicology and applied pharmacology. 2026;516:118036. DOI 10.1016/j.taap.2026.118036; PMID 42767517; PMCID PMC13670113.
[4] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
[5] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
[6] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
[8] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.
[9] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.
[10] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.
[11] Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Clinical epigenetics. 2016;8:107. DOI 10.1186/s13148-016-0276-4; PMID 27777636; PMCID PMC5062906.
Related reading
Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation
In this study, the biological effect and epigenetic regulation of calcitriol on kidney cancer cells were investigated.
Original paper ↗Read more →Chromatin and transcriptional dynamics underlying the immune-modulatory effects of vitamin D3 in vivo
Vitamin D3 is an essential micronutrient that supports innate immunity and modulates adaptive responses, with in vitro studies implicating epigenetic mechanisms.
Original paper ↗Read more →Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Original paper ↗Read more →Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation
We aimed to evaluate whether maternal vitamin D insufficiency during pregnancy was conditionally associated with DNA methylation in the offspring cord blood.
Original paper ↗Read more →Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial
In this study, we used an existing randomized trial to test the hypothesis that maternal gestational vitamin D supplementation would lead to reduced perinatal RXRA locus DNA methylation.
Original paper ↗Read more →Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations
Environmental perturbation of epigenetic mechanisms is linked to a growing number of diseases.
Original paper ↗Read more →Vitamin D, Chromatin Accessibility and Epigenetic Marks: Full Evidence Review
How vitamin D research measures DNA methylation, histone marks and chromatin accessibility, including human null findings and model-specific limitations.
Read more →VDR Cistrome, Chromatin and 3D Genome Organisation: Evidence Synthesis
Evidence synthesis of the VDR cistrome, chromatin accessibility, regulatory factors and 3D genome organisation in cell-specific signalling.
Read more →Characterization of Genomic Vitamin D Receptor Binding Sites through Chromatin Looping and Opening
The vitamin D receptor (VDR) is a transcription factor that mediates the genomic effects of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3).
Original paper ↗Read more →Vitamin D receptor and epigenetics in HIV infection and drug abuse
Illicit drug abuse is highly prevalent and serves as a powerful co-factor for HIV exacerbation.
Original paper ↗Read more →Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes
We found that calcitriol-treated HL-1 cells had significantly reduced FGFR1 expression compared to control cells.
Original paper ↗Read more →Differences in DNA Methylation in Genes Involved in Vitamin D Metabolism Are Related to Insulin Requirement in Pregnant Women with Gestational Diabetes Mellitus
This study aimed to investigate if insulin treatment in GDM affects DNA methylation in VitD metabolism genes.
Original paper ↗Read more →A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Original paper ↗Read more →Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits
We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.
Original paper ↗Read more →Downregulation and Hypermethylation of Vitamin D Receptor in Lumbar Disc Degeneration
The objective of this study was to examine cytokine expression and DNA methylation status of the VDR gene in blood leukocytes and lumbar disc tissues from patients with varying degrees of LDD severity.
Original paper ↗Read more →H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
Our study evaluated the expression level of histone 3 lysine 4 trimethylation (H3K4me3) in a cohort of 156 epithelial ovarian cancer (EOC) cases by immunohistochemical staining and analyzed its correlation to patient prognosis.
Original paper ↗Read more →Ligand‐Independent Actions of the Vitamin D Receptor: More Questions Than Answers
What is the purpose of the unliganded VDR?
Original paper ↗Read more →Osteoblast-Specific Transcription Factor Osterix Increases Vitamin D Receptor Gene Expression in Osteoblasts
For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria.
Original paper ↗Read more →The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia
To this end, we investigated whether the calcitriol/VDR system is functional in CLL and analyzed key signaling pathways that are regulated by calcitriol supplementation, while also exploring the role of microenvironmental signals in the regulation of calcitriol/VDR system.
Original paper ↗Read more →Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
To ensure that MeTC7 inhibits VDR/PD-L1 without off-target effects, we examined competitive inhibition of VDR by MeTC7, utilizing ligand-dependent dimerization of VDR-RXR, RXR-RXR, and VDR-coactivators in a mammalian 2-hybrid (M2H) assay.
Original paper ↗Read more →Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases
However, as these studies have some limitations, we recommend further randomized trials to clarify the link between vitamin D and its activity with eye disease.
Original paper ↗Read more →Original sources
Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF.
Published in Seuter S, Neme A, Carlberg C. Nucleic acids research (2016).
Publication details
[1] Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF. Seuter S, Neme A, Carlberg C. Nucleic acids research. 2016;44(9):4090-4104. DOI 10.1093/nar/gkv1519; PMID 26715761.
Chromatin and transcriptional dynamics underlying the immune-modulatory effects of vitamin D3 in vivo
Vitamin D3 is an essential micronutrient that supports innate immunity and modulates adaptive responses, with in vitro studies implicating epigenetic mechanisms.
Publication details
[2] Chromatin and transcriptional dynamics underlying the immune-modulatory effects of vitamin D3 in vivo. Rybiński M, Ghosh Dastidar R, Zawrotna N, Gospodarska E, Carlberg C. Scientific reports. 2026;16:2997. Published online 18 December 2025. DOI 10.1038/s41598-025-32831-z; PMID 41413700; PMCID PMC12830676.
Increased chromatin accessibility following 1α,25-dihydroxyvitamin D3 treatment in human endometrial stromal cells.
Published in Yi M, Bostan H, DeMayo FJ. Toxicology and applied pharmacology (2026).
Publication details
[3] Increased chromatin accessibility following 1α,25-dihydroxyvitamin D3 treatment in human endometrial stromal cells. Yi M, Bostan H, DeMayo FJ. Toxicology and applied pharmacology. 2026;516:118036. DOI 10.1016/j.taap.2026.118036; PMID 42767517; PMCID PMC13670113.
Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.
Published in Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget (2017).
Publication details
[4] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
Vitamin D Switches BAF Complexes to Protect β Cells.
[5] Vitamin D Switches BAF Complexes to Protect β Cells.
Publication details
[5] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
[6] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
Publication details
[6] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Publication details
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial
In this study, we used an existing randomized trial to test the hypothesis that maternal gestational vitamin D supplementation would lead to reduced perinatal RXRA locus DNA methylation.
Publication details
[8] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.
Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation
We aimed to evaluate whether maternal vitamin D insufficiency during pregnancy was conditionally associated with DNA methylation in the offspring cord blood.
Publication details
[9] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Publication details
[10] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.
Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations
Environmental perturbation of epigenetic mechanisms is linked to a growing number of diseases.
Publication details
[11] Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Clinical epigenetics. 2016;8:107. DOI 10.1186/s13148-016-0276-4; PMID 27777636; PMCID PMC5062906.